Editorial: Community series - Purple Haze: issues on cannabis legalization, volume II
- PMID: 37547207
- PMCID: PMC10402892
- DOI: 10.3389/fpsyt.2023.1241229
Editorial: Community series - Purple Haze: issues on cannabis legalization, volume II
Keywords: cannabis; harm reduction; legalization; policy; public health.
Conflict of interest statement
MP was employed by Connecticut Council on Problem Gambling. MP has consulted for Opiant Pharmaceuticals, Idorsia Pharmaceuticals, AXA, Game Day Data, Baria-Tek, and the Addiction Policy Forum; has been involved in a patent application with Yale University and Novartis; has received research support (to Yale) from Mohegan Sun Casino, Children and Screens and the Connecticut Council on Problem Gambling; has participated in surveys, mailings, or telephone consultations related to internet use, addictions, impulse-control disorders or other health topics; has consulted for and/or advised gambling and legal entities on issues related to impulse-control/addictive disorders; has provided clinical care in a problem gambling services program; has performed grant reviews for research funding agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Community series - Purple Haze: issues on cannabis legalization, volume II
References
Publication types
LinkOut - more resources
Full Text Sources